Atlanta Journal-Constitution

Study: Weekly insulin controls Type 2 diabetes patients’ blood sugar

A phase 2 clinical trial found safety and efficacy comparable to daily insulin There’s good news for Type 2 diabetes patients who hope to relax their daily insulin use. The Endocrine Society on Sunday ...
Business Wire

Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia

WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced positive data from the STARLYNG-1 (LYN-005-C-301) study, comparing the ...
Monthly Prescribing Reference

Study Shows Weekly Oral Risperidone Comparable to Daily Doses for Schizophrenia

LYN-005 is an investigational long-acting oral capsule formulation of the atypical antipsychotic risperidone. Positive data were announced from a phase 3 study comparing the pharmacokinetic (PK) ...
Nature

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

The objective of this study was to evaluate the efficacy and safety profile of weekly docetaxel, estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer. Forty-eight ...
PharmiWeb

In a fixed dose study, once weekly insulin efsitora alfa leads to HbA1C reduction similar to daily insulin

In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a second ...